article
8 June 2016 | By David S. Bailey (IOTA Pharmaceuticals), Sheraz Gul (Fraunhofer-IME SP)
Cancer cells exhibit huge phenotypic diversity, with many well-defined phenotypes, such as invasion, deregulated proliferation and immune evasion, contributing to disease outcomes, making them uniquely amenable to phenotypic screening1...